Last reviewed · How we verify
Maintain Patency of Indwelling Vascular Catheter
Approved treatments
- Heparin Sodium In Plastic Container · Merck & Co.
Heparin works by binding to Antithrombin-III, a protein that inhibits the formation of blood clots. - Heparin Sodium In Plastic Container · Fresenius Kabi
Heparin enhances Antithrombin III activity to inhibit coagulation factors Xa and IIa.
Clinical guidelines
- FDA label — 1L
Not explicitly mentioned in the provided text - FDA label — 1L
Not explicitly mentioned in the provided text - FDA label — 1L
Not explicitly mentioned in the provided text - FDA label — 1L
Not explicitly mentioned in the provided text - FDA label — 1L
Not explicitly mentioned in the provided text - FDA label — maintenance
Use as an anticoagulant to maintain patency of indwelling vascular catheters - FDA label — 1L
Not explicitly mentioned in the provided text - FDA label — 1L
Not explicitly mentioned in the provided text - FDA label — 1L
Not explicitly mentioned in the provided text - FDA label — 1L
Not explicitly mentioned in the provided text - FDA label — 1L
Not explicitly mentioned in the provided text - FDA label — maintenance
Not explicitly mentioned in the provided text, but inferred from the drug's anticoagulant properties - FDA label — 1L
Use as an anticoagulant in blood transfusions, extracorporeal circulation, and dialysis procedures
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Maintain Patency of Indwelling Vascular Catheter patent landscape — cliff calendar, originator estates, attackable patents
- Maintain Patency of Indwelling Vascular Catheter treatment landscape brief
- Maintain Patency of Indwelling Vascular Catheter treatment updates RSS
Frequently asked questions about Maintain Patency of Indwelling Vascular Catheter
What drugs treat Maintain Patency of Indwelling Vascular Catheter?
Tracked treatments include Heparin Sodium In Plastic Container.
What is the treatment for Maintain Patency of Indwelling Vascular Catheter?
Standard treatment for Maintain Patency of Indwelling Vascular Catheter includes Heparin Sodium In Plastic Container. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Maintain Patency of Indwelling Vascular Catheter?
FDA label publishes guidelines for Maintain Patency of Indwelling Vascular Catheter. 13 guideline references tracked.
Related
- Treatment landscape: Maintain Patency of Indwelling Vascular Catheter patent cliff · Maintain Patency of Indwelling Vascular Catheter CI report
- Treatment: Heparin Sodium In Plastic Container · Merck & Co.
- Treatment: Heparin Sodium In Plastic Container · Fresenius Kabi
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing